Healthcare >> CEO Interviews >> October 26, 2004
FRED KURLAND joined Corcept Therapeutics Incorporated as Chief Financial
Officer in February 2004. Mr. Kurland served as Vice President and Chief
Financial Officer of Genitope Corporation from 2002 until February 2004.
From 1998 to 2002 he served as Senior Vice President and Chief Financial
Officer of Aviron. Mr. Kurland served as Vice President and Chief
Financial Officer of Protein Design Labs, Inc., from 1996 to 1998. From
1995 to 1996, Mr. Kurland served as Vice President, Chief Financial
Officer and Secretary of Applied Immune Sciences, Inc. From 1991 to
1995, Mr. Kurland served as Vice President and Controller of Syntex
Corporation. Mr. Kurland received his BS from Lehigh University and his
JD and MBA degrees from the University of Chicago. Profile
DR. JOSEPH K. BELANOFF is a co-founder of Corcept Therapeutics
Incorporated and has served as a member of the Board of Directors and as
Chief Executive Officer since 1999. Dr. Belanoff is currently a faculty
member and has held various positions in the Department of Psychiatry
and Behavioral Sciences at Stanford University since 1992. From 1997 to
2001, he served as the Director of Psychopharmacology at the outpatient
division of the Palo Alto Veterans Affairs Hospital. Dr. Belanoff
received his BA from Amherst College and his MD from Columbia
University's College of Physicians & Surgeons. Profile
an overview of what you're currently doing?
Dr. Belanoff : Corcept was founded because we believed that it is
vitally
